Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation-Reference-Cited by-同舟云学术

Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

Published:2021-01 Issue:1 Volume:14 Page:100977
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Hodkinson Brendan P.,Schaffer Michael,Brody Joshua D.^ORCID,Jurczak Wojciech,Carpio Cecilia^ORCID,Ben-Yehuda Dina,Avivi Irit,Forslund Ann^ORCID,Özcan Muhit,Alvarez John,Ceulemans Rob,Fourneau Nele,Younes Anas,Balasubramanian Sriram

Funder

Janssen Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference68 articles.

1. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia;Byrd;N. Engl. J. Med.,2014

2. Single-agent ibrutinib in treatment-naive and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience;O'Brien;Blood,2018

3. Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2;Barr;Haematologica,2018

4. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study;Chanan-Khan;Lancet Oncol.,2016

5. Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma;Noy;Blood,2017

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific Mutation Predict Relapse/Refractory Diffuse Large B-Cell Lymphoma;Journal of Blood Medicine;2024-09

2. Simulating cell-free chromatin using preclinical models for cancer-specific biomarker discovery;2023-11-17

3. Sequencing‐based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy;American Journal of Hematology;2023-08-21

4. A performance evaluation of drug response prediction models for individual drugs;Scientific Reports;2023-07-24

5. Analysis of the genomic landscape of primary central nervous system lymphoma using whole-genome sequencing in Chinese patients;Frontiers of Medicine;2023-07-07